Back

Clofazimine population pharmacokinetics and target attainment in rifampicin-resistant Tuberculosis patients

2025-12-05 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

Clofazimine is a key component of the BPaLC regimen (bedaquiline, pretomanid, linezolid, and clofazimine), an investigational treatment for rifampicin-resistant tuberculosis (RR-TB). However, clofazimines elimination half-life has never been formally characterized amongst tuberculosis patients and a pharmacokinetic (PK) - pharmacodynamic (PD) endpoint for probability of target attainment (PTA) evaluations is lacking. To support dose optimization and efficacy interpretation, we developed a clofaz...

Predicted journal destinations

1
Clinical Pharmacology & Therapeutics
19 training papers
Top 0.3% 11.9%
2
European Respiratory Journal
44 training papers
Top 0.9% 6.5%
3
PLOS ONE
1737 training papers
Top 71% 6.5%
4
Nature Communications
483 training papers
Top 15% 6.5%
5
Scientific Reports
701 training papers
Top 37% 6.5%
6
Frontiers in Pharmacology
27 training papers
Top 0.4% 6.0%
7
Antimicrobial Agents and Chemotherapy
17 training papers
#1 6.0%
8
British Journal of Clinical Pharmacology
21 training papers
Top 0.5% 6.0%
9
The Journal of Infectious Diseases
137 training papers
Top 3% 4.2%
10
eLife
262 training papers
Top 10% 4.2%
11
Clinical Infectious Diseases
219 training papers
Top 12% 2.8%
12
American Journal of Respiratory and Critical Care Medicine
23 training papers
Top 1% 2.0%
13
Frontiers in Medicine
99 training papers
Top 13% 1.4%
14
PLOS Medicine
95 training papers
Top 11% 1.4%
15
eBioMedicine
82 training papers
Top 5% 1.4%
16
The Lancet Infectious Diseases
57 training papers
Top 5% 1.2%
17
The Lancet Microbe
33 training papers
Top 2% 1.0%
18
Journal of Antimicrobial Chemotherapy
19 training papers
Top 0.6% 1.0%
19
The Lancet Global Health
24 training papers
Top 0.8% 1.0%
20
PLOS Global Public Health
287 training papers
Top 34% 0.7%
21
PLOS Computational Biology
141 training papers
Top 14% 0.7%
22
Nature Medicine
88 training papers
Top 17% 0.7%
23
Open Forum Infectious Diseases
124 training papers
Top 16% 0.7%
24
BMC Medicine
155 training papers
Top 34% 0.7%
25
New England Journal of Medicine
49 training papers
Top 4% 0.7%
26
Nature
58 training papers
Top 10% 0.7%